Based on the provided data, the sales of antiinfective medicine in Chile displayed significant fluctuations over the past decade. From 2013 to 2023, sales increased from USD 423.9 million to USD 491.7 million, reflecting an overall upward trend with some periods of decline. In recent years, the market saw notable growth in 2018 and 2019, followed by a drop in 2021. However, the past two years have shown recovery, with sales increasing by 9.28% in 2022 and 9.83% in 2023.
The compounded annual growth rate (CAGR) for the last five years ending in 2023 stands at -2.15%, indicating a slight overall decline despite recent upticks. Looking forward, the sales are forecasted to continue their growth, reaching USD 581.8 million by 2028, with a forecasted 5-year CAGR of 2.67% and an overall forecasted 5-year growth rate of 14.1%.
Future trends to watch for include potential impacts of healthcare policies, advancements in medical treatments, and responses to emerging infectious diseases. Additionally, market dynamics influenced by local and global economic conditions, as well as innovation in antiinfective medications, could significantly affect future sales trajectories.
